Tag: Therapy & Procedures: Misc.
WHO: Plasma Therapy for COVID-19 Still Experimental
FDA 'emergency use authorization' does not mean plasma therapy has been proven safe and effective
FDA Approves Wider Use of Plasma as COVID-19 Treatment
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
More data are under review; the approval could still be issued in the near future
Evidence Poor for Accuracy of Serological Tests for COVID-19
Evidence for diagnostic accuracy of serological tests characterized by high risks of bias, heterogeneity
Convalescent Plasma Safe for Diverse Patients With COVID-19
Incidence of SAEs, including transfusion reactions, thromboembolic or thrombotic events, is low
Treatment Gap Remains in Stroke Care Between Men and Women
Size of this difference has narrowed compared with studies published before 2008
Pneumonia Risk Down With Nitrogen-Containing Bisphosphonates
Reductions in risk for pneumonia and pneumonia mortality seen among patients with hip fracture
Human Trial of Antibody Therapy to Treat COVID-19 Underway
If drug proves safe and effective, it could be available for use by the fall
Convalescent Plasma Appears Promising for Severe COVID-19
In series of 25 patients, 19 experienced improvement in clinical status by day 14; 11 were discharged
Pulmonary Rehab Associated With Lower COPD Mortality
Only 1.5 percent of patients initiated pulmonary rehabilitation within 90 days of discharge
